The Akt isoforms, their unique functions and potential as anticancer therapeutic targets

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The PI3K-Akt pathway is a key regulator of cellular functions and a validated target in cancer therapy.
• Constitutive activation of this pathway correlates with tumor progression and therapeutic resistance.

Purpose of the Study:

• To review the distinct roles and activation mechanisms of the three Akt isoforms (Akt1-3).
• To highlight their potential as targeted anticancer therapies.

Main Methods:

• Review of published in vitro and in vivo studies.
• Analysis of subcellular localization data for Akt isoforms.

Main Results:

• Accumulating evidence suggests unique activation modes and functions for Akt1, Akt2, and Akt3.
• Akt isoforms exhibit differential subcellular localization in adipocytes and cancer cells.

Conclusions:

• Each Akt isoform may possess unique functions and therapeutic potential.
• Targeting specific Akt isoforms could represent a novel strategy in cancer treatment.